Cambria Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.95M Sell
2,120
-150
-7% -$152K 0.11% 165
2025
Q4
$2.44M Buy
2,270
+842
+59% +$805K 0.14% 167
2025
Q3
$1.09M Buy
1,428
+1,026
+255% +$764K 0.07% 212
2025
Q2
$313K Buy
+402
New +$312K 0.02% 370
2019
Q4
Sell
-38,012
Closed -$4.25M 211
2019
Q3
$4.25M Buy
38,012
+500
+1% +$55.7K 0.64% 69
2019
Q2
$4.16M Buy
37,512
+188
+0.5% +$22.1K 0.64% 74
2019
Q1
$4.84M Sell
37,324
-754
-2% -$91.7K 0.75% 39
2018
Q4
$4.41M Sell
38,078
-7,529
-17% -$841K 0.75% 38
2018
Q3
$4.89M Sell
45,607
-4,113
-8% -$411K 0.72% 34
2018
Q2
$4.36M Sell
49,720
-7,981
-14% -$656K 0.65% 58
2018
Q1
$4.46M Sell
57,701
-12,700
-18% -$1.02M 0.65% 69
2017
Q4
$5.95M Buy
70,401
+1,496
+2% +$127K 0.83% 62
2017
Q3
$5.89M Buy
68,905
+44,387
+181% +$3.64M 0.91% 33
2017
Q2
$2.02M Buy
+24,518
New +$2M 0.43% 64
2015
Q3
Sell
-37,977
Closed -$3.17M 347
2015
Q2
$3.17M Buy
37,977
+264
+0.7% +$20.1K 0.97% 14
2015
Q1
$2.74K Buy
37,713
+1,848
+5% +$132K 0.31% 33
2014
Q4
$2.47M Buy
+35,865
New +$2.42M 0.88% 33

Other funds holding LLY

Cambria Investment Management's LLY Position: Q1 2026 in Review

Cambria Investment Management reduced its Eli Lilly (LLY) stake by 6.6% in Q1 2026, selling an estimated $152K and leaving 2,120 shares worth $1.95M. The position accounts for 0.11% of the portfolio, ranked #165.

Cambria Investment Management first reported a position in LLY in Q4 2014 and has held it in 17 quarters since. The position peaked at $5.95M in Q4 2017. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cambria Investment Management held 2,120 shares of Eli Lilly worth $1.95M as of Q1 2026.
  • Cambria Investment Management sold 150 Eli Lilly shares in Q1 2026, an estimated $152K.
  • Eli Lilly made up 0.11% of Cambria Investment Management's portfolio in Q1 2026, its #165 holding.
  • Cambria Investment Management first reported a position in Eli Lilly in Q4 2014 and has held it in 17 quarters since.
  • Cambria Investment Management's Eli Lilly position peaked at $5.95M in Q4 2017.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.